This compound is a pharmaceutical intermediate used in the manufacturing of dapagliflozin, a medication for type 2 diabetes, heart failure, and chronic kidney disease. It functions as a key building block in the synthesis of this SGLT-2 inhibitor.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 461432-24-6
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
pharmaceutical intermediate for dapagliflozin
4-Oxo-4-(p-tolyl)butanoic acid
Pharmaceutical intermediate for impurities
FLUOROBENZENE
Pharmaceutical intermediate
3-AMINOPYRIDINE
Pharmaceutical and agrochemical intermediate
(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
Pharmaceutical intermediate for dapagliflozin analogs
(2S,3R,4S,5S)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,6-bis(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
Pharmaceutical intermediate
(3R,4S,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol
GKTWLVVOULBRDU-VEIQOZLZSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3([C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OC)Cl
—